Effective vaccines, without a needle: Since the start of the COVID-19 pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize medicine.
Taipei, Nov. 1 (CNA) Medigen Vaccine Biologics Corp. is partnering with an American biotech company to develop a COVID-19 vaccine patch, which could begin human clinical trials as early as in 2022, the Taiwanese vaccine maker announced Monday.
Effective vaccines, without a needle: Since the start of the COVID pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize medicine. The technique could help save children's tears at doctors' offices, and help people who have…
Effective vaccines, without a needle: Since the start of the COVID pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize medicine. The.